» Articles » PMID: 25399736

Comparing Two Correlated C Indices with Right-censored Survival Outcome: a One-shot Nonparametric Approach

Overview
Journal Stat Med
Publisher Wiley
Specialty Public Health
Date 2014 Nov 18
PMID 25399736
Citations 171
Authors
Affiliations
Soon will be listed here.
Abstract

The area under the receiver operating characteristic curve is often used as a summary index of the diagnostic ability in evaluating biomarkers when the clinical outcome (truth) is binary. When the clinical outcome is right-censored survival time, the C index, motivated as an extension of area under the receiver operating characteristic curve, has been proposed by Harrell as a measure of concordance between a predictive biomarker and the right-censored survival outcome. In this work, we investigate methods for statistical comparison of two diagnostic or predictive systems, of which they could either be two biomarkers or two fixed algorithms, in terms of their C indices. We adopt a U-statistics-based C estimator that is asymptotically normal and develop a nonparametric analytical approach to estimate the variance of the C estimator and the covariance of two C estimators. A z-score test is then constructed to compare the two C indices. We validate our one-shot nonparametric method via simulation studies in terms of the type I error rate and power. We also compare our one-shot method with resampling methods including the jackknife and the bootstrap. Simulation results show that the proposed one-shot method provides almost unbiased variance estimations and has satisfactory type I error control and power. Finally, we illustrate the use of the proposed method with an example from the Framingham Heart Study.

Citing Articles

Population-specific genetic-risk scores enable improved prediction of mortality within 28 days of sepsis onset: a retrospective Taiwanese cohort study.

Hsieh M, Wu P, Chiu K, Liao S, Chen C, Hsiao T J Intensive Care. 2025; 13(1):11.

PMID: 40011956 PMC: 11863615. DOI: 10.1186/s40560-025-00783-1.


Proteome signature for differential diagnosis of patients with bilateral lung infiltrates.

Oh Y, Kim K, Kim H, Hong S, Lim C, Koh Y ERJ Open Res. 2025; 11(1).

PMID: 39963163 PMC: 11831621. DOI: 10.1183/23120541.00762-2024.


Plasma SVEP1 Levels Predict Cardiovascular Events in Hypertrophic Cardiomyopathy Beyond Conventional Clinical Risk Models Including NT-proBNP.

Osawa I, Akita K, Hasegawa K, Fifer M, Tower-Rader A, Reilly M Circ Heart Fail. 2025; 18(2):e012343.

PMID: 39831317 PMC: 11835532. DOI: 10.1161/CIRCHEARTFAILURE.124.012343.


Identifying biomarker-driven subphenotypes of cardiogenic shock: analysis of prospective cohorts and randomized controlled trials.

Soussi S, Tarvasmaki T, Kimmoun A, Ahmadiankalati M, Azibani F, Santos C EClinicalMedicine. 2025; 79():103013.

PMID: 39802301 PMC: 11718329. DOI: 10.1016/j.eclinm.2024.103013.


A novel machine learning-based immune prognostic signature for improving clinical outcomes and guiding therapy in colorectal cancer: an integrated bioinformatics and experimental study.

Zhao Y, Xun D, Chen J, Qi X BMC Cancer. 2025; 25(1):65.

PMID: 39794799 PMC: 11724613. DOI: 10.1186/s12885-025-13437-0.


References
1.
Greiner M, Pfeiffer D, Smith R . Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests. Prev Vet Med. 2000; 45(1-2):23-41. DOI: 10.1016/s0167-5877(00)00115-x. View

2.
Heagerty P, Lumley T, Pepe M . Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics. 2000; 56(2):337-44. DOI: 10.1111/j.0006-341x.2000.00337.x. View

3.
Begg C, Cramer L, Venkatraman E, Rosai J . Comparing tumour staging and grading systems: a case study and a review of the issues, using thymoma as a model. Stat Med. 2000; 19(15):1997-2014. DOI: 10.1002/1097-0258(20000815)19:15<1997::aid-sim511>3.0.co;2-c. View

4.
Metz C . Basic principles of ROC analysis. Semin Nucl Med. 1978; 8(4):283-98. DOI: 10.1016/s0001-2998(78)80014-2. View

5.
DAWBER T, MEADORS G, MOORE Jr F . Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health Nations Health. 1951; 41(3):279-81. PMC: 1525365. DOI: 10.2105/ajph.41.3.279. View